Peptide API Liraglu...

Peptide API Liraglutide/Liraglutide acetate CAS 204656-20-2
Peptide API Liraglutide/Liraglutide acetate CAS 204656-20-2

Peptide API Liraglutide/Liraglutide acetate CAS 204656-20-2

Min.Order / FOB Price:Get Latest Price

1 Gram

Negotiable

  • Min.Order :1 Gram
  • Purity: 98% Min
  • Payment Terms : T/T,,MoneyGram

Keywords

Liraglutide supplier, peptide hormone Liraglutide acetate Liraglutide manufacturer

Quick Details

  • Appearance:White powder
  • Application:pharmaceutical ingredients ,research chemicals
  • PackAge:According client's requirements
  • ProductionCapacity:200|Gram|Day
  • Storage:keep sealed and keep from direct light
  • Transportation:According client's requirements

Superiority:

Our Advantages:

1.Product Capacity: eptidego has produced thousands of peptides ranging in quantity from milligrams to multiple kilograms with purities up to 99.0%. 

2. Samples free trial:     our company welcome samples to test our quality then make regular orders.

3. Good Service: the company have 24 hours online service and feedback to our clients ontime

4. Quality guarantee:  We have strict quality control system before our delivery and refunds or re-deliver if any quality problems.

5. Fast Delivery and safe shipping:   The compnay process orders in time and have much experienced in internation shipping, always keep goods safe shipping and fast delivery.

Details:

About Liraglutide/Liraglutide acetate CAS 204656-20-2

 

 Name  Liraglutide/Liraglutide acetate
 Synonyms  NN 2211; NNC 90-1170; Victoza
 CAS NO.  204656-20-2

 Molecular Formula

 C172H265N43O51
 Molecular Weight  3751.20
 Appearance  White Powder
 Purity  99% Min

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment oftype 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. and E.U. under the brand name Saxenda as a treatment for adults, who are obese or overweight with at least one weight-relatedcomorbid condition.

Usage

Liraglutide is a once-daily injectable derivative of the human incretin (metabolic hormoneglucagon-like peptide-1 (GLP-1), for the treatment of type 2 diabetes or obesity.

Test

Specification

Result

Appearance

White powder

conforms

MS

3751.3±1.0

conforms

Related Substances

(purity)

Unspecified impurity

for each impurity: NMT1.0%

 

Total impurity: NMT 2.0%

 

0.29%(single largest impurity)

 

1.18%

Acetic acid

NMT 8.0%

0.5%

Water Content(Karl Fischer)

NMT 7.0%

4.8%

Peptide Content(N%)

NLT80%

94.5%

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View